comparing glp-1 agonists receptor Meta-analysis comparing effects of short-and
Description
In clinical trials, once-weekly semaglutide at diabetes doses (0.51 mg) produces mean weight loss of 46 kg (913 lbs), while the 2.4 mg dose (Wegovy) achieves average weight reductions of 1215% of body weight
Mood symptoms Animal studies, case reports, and a meta-analysis of RCTs of GLP-1 RAs suggest that these medications might help with depression (Chen X et al, Am J Geriatr Psychiatry 2024;32(1):117127)
No language restriction was applied
doi: 10.1056/NEJMoa2313917
In preclinical studies, GIP and GLP1 reduce atherosclerosis
Drug Saf
